Saltar al contenido
Merck

Documentos clave

Ver Toda la documentación

860549P

Avanti

C24:1 Glucosyl(β) Ceramide (d18:1/24:1(15Z))

Avanti Research™ - A Croda Brand

Sinónimos:

D-glucosyl-β-1,1′-N-nervonoyl-D-erythro-sphingosine

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño

Cambiar Vistas

Acerca de este artículo

Fórmula empírica (notación de Hill):
C48H91NO8
Número CAS:
887907-50-8
Peso molecular:
810.24
MDL number:
MFCD22416611
UNSPSC Code:
12352211
NACRES:
NA.25
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarle

Nombre del producto

C24:1 Glucosyl(β) Ceramide (d18:1/24:1(15Z)), Avanti Research™ - A Croda Brand 860549P, powder

assay

>99% (TLC)

form

powder

packaging

pkg of 1 × 5 mg (860549P-5mg)

manufacturer/tradename

Avanti Research™ - A Croda Brand 860549P

lipid type

sphingolipids

shipped in

dry ice

storage temp.

−20°C

SMILES string

[H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCCCCCCCC/C=C\CCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@@H]([C@H]1CO)O

InChI

1S/C48H91NO8/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-23-24-26-28-30-32-34-36-38-44(52)49-41(40-56-48-47(55)46(54)45(53)43(39-50)57-48)42(51)37-35-33-31-29-27-25-16-14-12-10-8-6-4-2/h17-18,35,37,41-43,45-48,50-51,53-55H,3-16,19-34,36,38-40H2,1-2H3,(H,49,52)/

InChI key

WBOZIXHPUPAOIA-JZZPSRGZSA-N

General description

β-Glucosylceramides or glucocerebrosides (GlcCers) are synthesized from the glycosphingolipids by β-GlcCer synthase. They are synthesized in Golgi and endoplasmic reticulum and localized in the cytosolic side of cell membrane. GlcCers are omnipresent.

Application

C24:1 Glucosyl(β) Ceramide (d18:1/24:1(15Z)) may be used:
  • as a standard hexosylceramide for hydrophilic interaction chromatography-based liquid chromatography mass spectroscopy
  • to test its nuclear factor of activated T-cells (NFAT) activation
  • in human natural killer T (NKT) cell potency assays

Biochem/physiol Actions

β-Glucosylceramides (β-GlcCer) levels are elevated inlevels in Gaucher′s disease, due to the deficiency of β-glucosidase. β-GlcCer participates in the inflammatory and acquired immune responses by binding mincle on myeloid cells and has immunostimulatory activity.

Packaging

5 mL Amber Glass Screw Cap Vial (860549P-5mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Clase de almacenamiento

11 - Combustible Solids

Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.

Si necesita más asistencia, póngase en contacto con Atención al cliente

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Potent neutralizing anti-CD1d antibody reduces lung cytokine release in primate asthma model
Nambiar J, et al.
MAbs, 7(3), 638-650 (2015)
3-O-sulfo-beta-d-galactose moiety of endogenous sulfoglycolipids is a potential ligand for immunoglobulin-like receptor LMIR5
Phongsisay V, et al.
Molecular Immunology, 63(2), 595-599 (2015)
Diastereomer-specific quantification of bioactive hexosylceramides from bacteria and mammals
Von Gerichten J, et al.
Journal of Lipid Research, 58(6), 1247-1258 (2017)
Ver todos los artículos relacionados